Back to Screener

Financial Services

Amplify Seymour Cannabis ETF(CNBS)

Live Price

Offline

$29.03

+3.85% today

1Y Change

+77.49%

Window

Jun 25, 2025 โ†’ Jun 23, 2026

Market Cap
$90.00M
Revenue Growth
0.0%
EPS Growth
0.0%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 25, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Amplify Seymour Cannabis ETF (CNBS) is a Financial Services stock with a market cap of $90.00M and listed on NYSE. The stock last traded around $29.03 and up 77.5% across the available one-year price window (Jun 25, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines CNBS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +3.4% peer median

Operating Margin

Below sector median

0.0% vs +4.7% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

The setup is mixed rather than one-directional

Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 0.0%.

Benchmark Edge

CNBS vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CNBS

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CNBS Max Drawdown

-51.25%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CNBS and SPY.

Calendar-year return history is still loading or unavailable.
AM

Company Overview

Amplify Seymour Cannabis ETF

NYSE

United States

The Amplify Seymour Cannabis ETF is an exchange-traded fund (ETF) focused on providing exposure to the growing cannabis industry. Its primary purpose is to offer investors access to companies that are actively involved in the legal marijuana, hemp, and CBD sectors. This ETF is actively managed, selecting holdings based on an extensive analysis of the cannabis market landscape. Notable features of the Amplify Seymour Cannabis ETF include diversification across various segments of the cannabis value chain, including cultivation, production, and distribution of cannabis and related products. The ETF primarily impacts industries such as pharmaceuticals, personal care, agriculture, and biotechnology, leveraging the expanding legal cannabis market's potential. It holds significance in financial markets as it offers investors a tool to participate in an evolving sector that is increasingly being recognized for its economic contributions. The Amplify Seymour Cannabis ETF plays a critical role by channeling investment towards the cannabis industry, reflecting the growing acceptance and regulatory changes surrounding cannabis use worldwide.

Region
United States
Last Updated
May 8, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
โ€”

Growth

Revenue
0.0%
EPS
0.0%
Free Cash Flow
0.0%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.0%
ROIC
0.0%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
โ€”

Earnings Reports

No earnings data available

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.